GlaxoSmithKline Research & Development
Research Triangle Park, NC 27709 (Map) Phone: 919-483-2100
Fax: 919-549-7459
http://www.gsk.com/research
Overview
GlaxoSmithKline Research & Development (GSK R&D) is the actual pipeline filled with products in various stages of completion for pharmaceutical giant GlaxoSmithKline. With multiple locations in the US, across Europe, and in Asia, the company has treatments in the works for ailments in areas such as infectious disease, neurology, cardiovascular, metabolic, oncology, and respiratory needs. It has approximately 150 drugs in clinical development stages, including about 30 in late-stage trials. The organization's facilities are grouped into Discovery Performance Units (preclinical), Centres of Excellence for Drug Discovery (early stage clinical), and Medicine Development Centres (late-stage clinical).
Sample OverviewKey Numbers from Hoover's UK
Key financials for GlaxoSmithKline Research & Development
| Company Type | Business Segment of GlaxoSmithKline |
|---|
Key People from Hoover's UK
Key people and executives for GlaxoSmithKline Research & Development
| Chairman | Moncef Slaoui (Subscribers see complete biographies -- view sample)
|
|---|---|
| CEO | Andrew Witty |
| Chief of Staff | Daniel J. (Dan) Phelan |
Top Competitors from Hoover's UK
Top competitors of GlaxoSmithKline Research & Development
There are 18 competitors for GlaxoSmithKline R & D; see more.
